MOUNTAIN VIEW, Calif., June 18 /PRNewswire/ -- Aviron (Nasdaq: AVIR) today
announced that it is calling all of its outstanding 5 3/4 percent Convertible
Subordinated Notes due 2005 for redemption on July 18, 2001. The redemption
price for the Notes will be 103.286 percent of the principal amount plus
accrued and unpaid interest from April 1, 2001 to the redemption date. No
interest will accrue on the Notes on or after July 18, 2001.
On June 15, 2001, $14,785,000 aggregate principal amount of Notes were
outstanding.
The Notes must be surrendered for payment at the address set forth below:
HSBC Bank USACorporate Trust Operations
One Hanson Place, Lower Level
Brooklyn, NY 11243
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
To receive an index and copies of recent press releases, call Aviron's
News-On-Call toll-free fax service, 800-758-5804, extension 114000.
Additional information about the company can be located at
http://www.aviron.com .
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html or fax,
800-758-5804, ext. 114000
CONTACT:
media, Benjamin Butkus of Fleishman-Hillard,
212-453-2000, for Aviron; or media and investors, John Bluth,
650-919-3716, or Asha Jennings, 650-919-1429, or investors only,
Fred Kurland, 650-919-6666, all of Aviron
|
